The uncertainty surrounding the grounds on which compulsory licenses on patented drugs may be granted and lengthy legal proceedings endanger the vitality of the Indian intellectual property (IP) environment. An even greater threat, perhaps the greatest, is the uncertainty surrounding biologic drugs. On what grounds? Significant uncertainty surrounds the grounds on which the Indian government … Continue reading Guest column: Indian patent rulings and the IPR ecosystem
Apothecurry 